Fondaparinux Sodium (Dr. Reddy’s Laboratories Inc.)
Welcome to the PulseAid listing for the Fondaparinux Sodium drug offered from Dr. Reddy’s Laboratories Inc.. This Factor Xa Inhibitor [EPC],Factor Xa Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Dr. Reddy’s Laboratories Inc. |
NON-PROPRIETARY NAME: | Fondaparinux Sodium |
SUBSTANCE NAME: | FONDAPARINUX SODIUM |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Factor Xa Inhibitor [EPC],Factor Xa Inhibitors [MoA] |
ROUTE: | SUBCUTANEOUS |
DOSAGE FORM: | INJECTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2017-07-27 |
END MARKETING DATE: | 0000-00-00 |
Fondaparinux Sodium HUMAN PRESCRIPTION DRUG Details:
Item Description | Fondaparinux Sodium from Dr. Reddy’s Laboratories Inc. |
LABELER NAME: | Dr. Reddy’s Laboratories Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 10(mg/.8mL) |
START MARKETING DATE: | 2017-07-27 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 43598-606_d8df1384-a587-0531-3416-25a63201409d |
PRODUCT NDC: | 43598-606 |
APPLICATION NUMBER: | ANDA091316 |
Other FONDAPARINUX SODIUM Pharmaceutical Manufacturers / Labelers: